What Happened
Panama’s Anti-Corruption Prosecutor’s Office carried out an on-site inspection this week at the Social Security Fund (CSS) drug warehouse in Pedregal, Panama district, as part of an ongoing probe into the disappearance of 19,000 vials of fentanyl that were registered missing in November 2022. The proceedings are being led by prosecutor Digna Castillo. Authorities say the investigation remains active and that no suspects have been formally identified.
Investigation and Audits
In 2023 the Public Prosecutor’s Office (MP) assembled a multidisciplinary team to audit how fentanyl and other controlled substances were handled. That team included officials from the Institute of Legal Medicine and Forensic Sciences at the University of Panama, a representative from the Nursing Faculty, and a physician from the Faculty of Medicine. The results of the MP-led review are to be compared with a separate report prepared by the Social Security Institute.
Separately, the CSS conducted an internal audit that revealed a series of irregularities in the management of controlled medications. Those findings prompted the Social Security Fund to apply stricter administrative measures for the handling and control of such drugs.
Background
Fentanyl is an exceptionally potent synthetic opioid. The reporting notes it is about 50 times more potent than heroin and that criminal groups frequently mix fentanyl with other substances — including heroin, methamphetamines and cocaine — to increase potency. In countries such as the United States and Mexico, fentanyl is also sold in tablet form. The drug is highly addictive and can be deadly for users even in small amounts.
What This Means
The loss of a large quantity of fentanyl from a government medical warehouse raises multiple concerns: the public-health risk posed if controlled substances are diverted into illicit channels; questions about inventory, chain-of-custody and internal controls at institutions responsible for medicines; and the potential reputational impact on the CSS. While authorities have not named suspects, the participation of forensic and medical experts signals an effort to determine how the loss occurred and whether the missing vials were mishandled, misplaced or diverted.
Next Steps
The Anti-Corruption Prosecutor’s Office is continuing its on-site review and forensic comparisons, and the multidisciplinary audit team’s findings will be weighed alongside the Social Security Institute and CSS internal reports. Investigators say they are searching for evidence that could clarify the possible fate of the 19,000 vials reported missing in November 2022.